MedTrace Logo

CRI in POTS in Adolescents

NCT03974737 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 77

Last updated 2021-01-26

No results posted yet for this study

Summary

The investigators aim to study whether the Compensatory Reserve Index (CRI) (an FDA approved device that assesses intravascular volume) can be used to evaluate severity of Postural Orthostatic Tachycardia Syndrome (POTS) and whether the CRI value has a correlation with severity of psychosocial symptoms and functional impairment associated with POTS.

Conditions

  • Postural Orthostatic Tachycardia Syndrome

Interventions

DEVICE

CRI device (non-invasive vitals sign measurement)

Survey administration, Orthostatic vital measurements

Sponsors & Collaborators

  • Colorado Clinical & Translational Sciences Institute

    collaborator OTHER

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Clio Pitula, PhD · Children's Hospital Colorado

Eligibility

Min Age
12 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-06-01
Primary Completion
2020-09-01
Completion
2020-09-22
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03974737 on ClinicalTrials.gov